Simultaneous versus staged resection for synchronous colorectal liver metastases: A population-based cohort study
- PMID: 31843676
- DOI: 10.1016/j.ijsu.2019.12.009
Simultaneous versus staged resection for synchronous colorectal liver metastases: A population-based cohort study
Abstract
Background: Synchronous liver metastases from colorectal cancer may be resected simultaneously with the primary or as a second staged operation. We evaluated trends of resection for synchronous colorectal cancer liver metastases and associated patient outcomes.
Methods: This is a retrospective cohort study that included patients undergoing resection for synchronous colorectal cancer liver metastases from 2006 to 2015 in the province of Ontario, Canada (population 13 million). Simultaneous resections occurred on the same admission, while staged resections occurred less than 6 months apart. Outcomes included postoperative complications, length of hospital stay, and overall survival. Kaplan Meier survival estimates, Cox proportional hazard models and logistic regression were used.
Results: Among 2,738 patients undergoing resection for colorectal cancer liver metastases, 1168 (42%) had synchronous disease. Of these, 442 resections were simultaneous (38%) and 776 were staged (62%). The proportion of synchronous disease among patients undergoing resection increased on average 3% per year (p = 0.02). For simultaneous versus staged resection, respectively, median length of hospital stay was shorter (8 vs. 11 days, p < 0.001); rate of major liver resections was lower (17% vs. 65%, p < 0.001), major postoperative complications were similar (28% vs. 23%, p = 0.067), and 90-day post-operative mortality was higher (6% vs. 1%, p < 0.001). Chemotherapy was administered more commonly among patients undergoing staged resections (91% vs. 76%, p < 0.001). Simultaneous resection was associated with a lower median overall survival (40 months, 95%CI 35-46 vs. 78 months, 95%CI 59-86). Risk factors for lower survival included higher comorbidities, right-sided primary and simultaneous resection.
Conclusion: Simultaneous resection was associated with similar postoperative complications, higher postoperative mortality and poorer long-term survival. Prospective randomized trials can inform the role of simultaneous versus staged resection for synchronous colorectal cancer liver metastases.
Keywords: Colorectal cancer; Colorectal liver metastases; Population-based study; Simultaneous resection; Synchronous metastases.
Copyright © 2019 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest We have nothing to declare.
Comment in
-
A commentary on "Simultaneous versus staged resection for synchronous colorectal liver metastases: A population-based cohort study". Importance of avoiding any other additional risk in selected patients with synchronous colorectal liver metastases.Int J Surg. 2020 Feb;74:111-112. doi: 10.1016/j.ijsu.2020.01.006. Epub 2020 Jan 14. Int J Surg. 2020. PMID: 31953053 No abstract available.
-
A commentary on"Simultaneous versus staged resection for synchronous colorectal liver metastases: A population-based cohort study" synchronous colorectal liver metastases: simultaneous or staged resection?Int J Surg. 2020 Feb;74:118-119. doi: 10.1016/j.ijsu.2020.01.010. Epub 2020 Jan 14. Int J Surg. 2020. PMID: 31953054 No abstract available.
Similar articles
-
Simultaneous versus staged resection for synchronous colorectal liver metastases: A population-based cost analysis in Ontario, Canada - Health economic evaluation.Int J Surg. 2020 Jun;78:75-82. doi: 10.1016/j.ijsu.2020.04.044. Epub 2020 Apr 23. Int J Surg. 2020. PMID: 32335234
-
Simultaneous versus staged resection for synchronous colorectal cancer liver metastases.J Am Coll Surg. 2009 May;208(5):842-50; discussion 850-2. doi: 10.1016/j.jamcollsurg.2009.01.031. Epub 2009 Mar 26. J Am Coll Surg. 2009. PMID: 19476847
-
Trends and outcomes of simultaneous versus staged resection of synchronous colorectal cancer and colorectal liver metastases.Surgery. 2021 Jul;170(1):160-166. doi: 10.1016/j.surg.2021.01.041. Epub 2021 Mar 3. Surgery. 2021. PMID: 33674128
-
Simultaneous versus staged colorectal and hepatic resections for colorectal cancer with synchronous hepatic metastases: a meta-analysis of outcomes and clinical characteristics.Int J Colorectal Dis. 2020 Sep;35(9):1629-1650. doi: 10.1007/s00384-020-03694-9. Epub 2020 Jul 11. Int J Colorectal Dis. 2020. PMID: 32653951 Review.
-
Simultaneous versus delayed resection of synchronous colorectal liver metastases: A systematic review and meta-analysis.Eur J Surg Oncol. 2025 May;51(5):109732. doi: 10.1016/j.ejso.2025.109732. Epub 2025 Feb 28. Eur J Surg Oncol. 2025. PMID: 40048802
Cited by
-
Synchronous Colorectal Liver Metastases considering Infectious Complications: Simultaneous or Delayed Surgery?Evid Based Complement Alternat Med. 2022 Oct 11;2022:5268554. doi: 10.1155/2022/5268554. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Oct 4;2023:9853204. doi: 10.1155/2023/9853204. PMID: 36267088 Free PMC article. Retracted.
-
Management of Colorectal Cancer with Synchronous Liver Metastases: An Inception Cohort Study (CoSMIC).Ann Surg Oncol. 2022 Mar;29(3):1939-1951. doi: 10.1245/s10434-021-11017-7. Epub 2021 Oct 30. Ann Surg Oncol. 2022. PMID: 34716838
-
Simultaneous resection of synchronous colorectal liver metastasis: Feasibility and development of a prediction model.Ann Hepatobiliary Pancreat Surg. 2023 Feb 28;27(1):40-48. doi: 10.14701/ahbps.22-043. Epub 2022 Sep 28. Ann Hepatobiliary Pancreat Surg. 2023. PMID: 36168272 Free PMC article.
-
Simultaneous versus staged major hepatectomy (≥3 liver segments) for outcomes of synchronous colorectal liver metastases: A systematic review and meta-analysis.Cancer Rep (Hoboken). 2022 Aug;5(8):e1617. doi: 10.1002/cnr2.1617. Epub 2022 Jun 26. Cancer Rep (Hoboken). 2022. PMID: 35753719 Free PMC article.
-
Simultaneous resection of colorectal cancer and synchronous liver metastases: what determines the risk of unfavorable outcomes? An international multicenter retrospective cohort study.Int J Surg. 2023 Mar 1;109(3):244-254. doi: 10.1097/JS9.0000000000000068. Int J Surg. 2023. PMID: 37093069 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical